Immunome's total assets for Q1 2026 were $619.79M, a decrease of -9.28% from the previous quarter. IMNM total liabilities were $31.11M for the fiscal quarter, a -36.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.